Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Connecting and Innovating for Better Health

We come from many disciplines and backgrounds, united by a vision of a world where better information empowers people to end disease and realize true health.

Building tools and infrastructure, creating care models, and sharing and enabling research are the ways our dedicated investigators and staff express commitment to improving patients’ lives. Their stories fuel our pursuit of the best possible health care for all people. Learn more about how you can join us in revolutionizing care.

Explore our work

Regenstrief Public License

Latest News

January 26, 2022 • News
AI models can predict individual risk of hospitalization for COVID using HIE data
AI models can predict individual risk of hospitalization for COVID using HIE data
Regenstrief study demonstrates how clinical data from healthcare systems can be used to better inform public health decision-making The COVID-19 pandemic has highlighted both the necessity and the difficulty of using clinical data to inform state and national public health policymaking. In a new study, Regenstrief Institute and Indiana University researchers demonstrate that machine learning […]
Continue Reading >
January 24, 2022 • News
Local mask policy matters when it comes to public health
Local mask policy matters when it comes to public health
Findings from a new study show impact of mask mandates on behavior  Local mask policies are strong influencers on mask-wearing behavior, according to new research from Regenstrief Institute, Indiana University Richard M. Fairbanks School of Public Health and Resolve to Save Lives.   Policies requiring face masks in public have been one strategy to address the […]
Continue Reading >
January 21, 2022 • News
Three doses of mRNA COVID-19 vaccines are very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variations of the virus
Three doses of mRNA COVID-19 vaccines are very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variations of the virus
New CDC study provides strong evidence that vaccines successfully combat severe disease A nationwide study from the Centers for Disease Control and Prevention (CDC) has found that mRNA booster shots (either Pfizer or Moderna) are 82 percent effective in protecting against COVID-19 Omicron variant-associated emergency department (ED) visits and 90 percent effective in protecting against […]
Continue Reading >
More News